Author

L. Esquivies

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. T. Brunger· 2 shared A. J. B. Kreutzberger· 1 shared B. Czako· 1 shared B. Dickey· 1 shared C. A. Doyle· 1 shared C. Wang· 1 shared G. Balistreri· 1 shared J. Cross· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. T. Brunger

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivAug 11, 2022

Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the pre-hairpin intermediate of the spike protein

K. Yang, C. Wang, A. J. B. Kreutzberger…·A. T. Brunger

DOI 10.1073/pnas.2210990119

experimental assayhost-pathogen & immune response

𝕏 PostBluesky

Pharmacology & ToxicologybioRxivMar 21, 2022

Screening of hydrocarbon-stapled peptides for inhibition of calcium-triggered exocytosis

Y. Lai, M. Tuvim, J. Leitz…·A. T. Brunger

The paper screens hydrocarbon-stapled peptides targeting the SNARE-Syt1 primary interface to inhibit Ca2+-triggered exocytosis and mucus hypersecretion.

DOI 10.3389/fphar.2022.891041

experimental assaydrug response / drug discovery

𝕏 PostBluesky